Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Pointreau

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 12, 2010
[Delineation variation of lung cancer in conformal radiotherapy among radiation oncology residents after an educational course: a prospective study]S Dewas, C Vautravers-Dewas, P Blanchard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 8, 2022
Head and neck cancers volume reduction: should we reduce our prophylactic node radiation to spare the antitumor immune response?Y El Houat, L Bouvier, M Baty, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 28, 2026
Discontinuation of the double-blind, placebo-controlled randomized, phase III GORTEC 2022-01 trial of radiotherapy-cetuximab and xevinapant in patients with locally advanced squamous cell carcinoma of the head and neck, unfit for cisplatinY Pointreau, A Larnaudie, X S Sun, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 12, 2023
[Clinical research in general hospital centres in France, strengths and weaknesses]D Argo-Leignel, P Bouju, M Le Saux, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 14, 2016
[Radiotherapy of larynx cancers]Y Pointreau, C Lafond, F Legouté, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 15, 2016
[Radiotherapy of hypopharynx cancers]Y Pointreau, C Lafond, P Trémolières, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 12, 2016
[Intensity modulated radiotherapy for head and neck cancer, dose constraint for normal tissue: Cochlea vestibular apparatus and brainstem]V Guimas, J Thariat, P Graff-Cailleau, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 20, 2017
A large French multicenter retrospective series of T1-T2N0 vocal cords carcinomas treated with exclusive irradiationA Robert, Y Pointreau, G Janoray, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 10, 2009
[Demography of radiation oncology residents in France in 2008: current situation and perspectives for the next three years]S Dewas, Y Pointreau, S Rivera, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 26, 2021
Radiotherapy for oral cavity cancersM Lapeyre, S Racadot, S Renard, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 12, 2010
[Delineation variation of lung cancer in conformal radiotherapy among radiation oncology residents after an educational course: a prospective study]S Dewas, C Vautravers-Dewas, P Blanchard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 8, 2022
Head and neck cancers volume reduction: should we reduce our prophylactic node radiation to spare the antitumor immune response?Y El Houat, L Bouvier, M Baty, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 28, 2026
Discontinuation of the double-blind, placebo-controlled randomized, phase III GORTEC 2022-01 trial of radiotherapy-cetuximab and xevinapant in patients with locally advanced squamous cell carcinoma of the head and neck, unfit for cisplatinY Pointreau, A Larnaudie, X S Sun, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 12, 2023
[Clinical research in general hospital centres in France, strengths and weaknesses]D Argo-Leignel, P Bouju, M Le Saux, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 14, 2016
[Radiotherapy of larynx cancers]Y Pointreau, C Lafond, F Legouté, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 15, 2016
[Radiotherapy of hypopharynx cancers]Y Pointreau, C Lafond, P Trémolières, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 12, 2016
[Intensity modulated radiotherapy for head and neck cancer, dose constraint for normal tissue: Cochlea vestibular apparatus and brainstem]V Guimas, J Thariat, P Graff-Cailleau, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 20, 2017
A large French multicenter retrospective series of T1-T2N0 vocal cords carcinomas treated with exclusive irradiationA Robert, Y Pointreau, G Janoray, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 10, 2009
[Demography of radiation oncology residents in France in 2008: current situation and perspectives for the next three years]S Dewas, Y Pointreau, S Rivera, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 26, 2021
Radiotherapy for oral cavity cancersM Lapeyre, S Racadot, S Renard, et al.
Pageof 9